A detailed history of Allspring Global Investments Holdings, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 276,531 shares of UTHR stock, worth $99.1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
276,531
Previous 184,934 49.53%
Holding current value
$99.1 Million
Previous $42.5 Million 107.35%
% of portfolio
0.15%
Previous 0.07%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$228.26 - $319.04 $20.9 Million - $29.2 Million
91,597 Added 49.53%
276,531 $88.1 Million
Q1 2024

Apr 18, 2024

BUY
$210.76 - $249.51 $745,458 - $882,516
3,537 Added 1.95%
184,934 $42.5 Million
Q4 2023

Jan 25, 2024

SELL
$214.88 - $256.94 $3.99 Million - $4.77 Million
-18,571 Reduced 9.29%
181,397 $39.9 Million
Q3 2023

Oct 27, 2023

BUY
$211.82 - $248.24 $42.4 Million - $49.6 Million
199,968 New
199,968 $45.2 Million
Q2 2023

Jul 18, 2023

SELL
$205.19 - $232.99 $4.47 Million - $5.07 Million
-21,763 Reduced 11.18%
172,926 $38.2 Million
Q1 2023

Apr 13, 2023

BUY
$212.99 - $276.17 $15.7 Million - $20.3 Million
73,643 Added 60.84%
194,689 $43.6 Million
Q4 2022

Jan 23, 2023

SELL
$205.95 - $280.43 $21.6 Million - $29.4 Million
-104,816 Reduced 46.41%
121,046 $33.7 Billion
Q3 2022

Oct 26, 2022

SELL
$203.3 - $244.17 $2.75 Million - $3.31 Million
-13,541 Reduced 5.66%
225,862 $47.3 Million
Q2 2022

Jul 25, 2022

SELL
$174.81 - $241.14 $14.2 Million - $19.5 Million
-81,056 Reduced 25.29%
239,403 $56.4 Million
Q1 2022

May 02, 2022

SELL
$166.16 - $213.96 $6.33 Million - $8.15 Million
-38,082 Reduced 10.62%
320,459 $57.5 Million
Q4 2021

Jan 28, 2022

BUY
$184.32 - $216.08 $66.1 Million - $77.5 Million
358,541 New
358,541 $77.5 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.